Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 62016CO0611(01)

Parandamise kohtumäärus, 3.9.2021.
Xellia Pharmaceuticals ApS ja Alpharma, LLC, varem Zoetis Products LLC versus Euroopa Komisjon.
Kohtuasi C-611/16 P.

ECLI identifier: ECLI:EU:C:2021:707

 ORDER OF THE COURT (Fourth Chamber)

3 September 2021 ( *1 )

(Rectification of judgment)

In Case C‑611/16 P‑REC,

APPEAL under Article 56 of the Statute of the Court of Justice of the European Union, brought on 25 November 2016,

Xellia Pharmaceuticals ApS, established in Copenhagen (Denmark),

Alpharma LLC, formerly Zoetis Products LLC, established in Parsippany, New Jersey (United States),

represented by D.W. Hull, Solicitor,

appellants,

the other parties to the proceedings being:

European Commission, represented by F. Castilla Contreras, T. Vecchi, B. Mongin and C. Vollrath, acting as Agents, and B. Rayment, Barrister,

defendant at first instance,

supported by:

United Kingdom of Great Britain and Northern Ireland, represented initially by D. Guðmundsdóttir, Z. Lavery and D. Robertson, acting as Agents, and J. Holmes QC, and subsequently by D. Guðmundsdóttir, acting as Agent, and J. Holmes QC,

intervener in the appeal,

THE COURT (Fourth Chamber),

composed of M. Vilaras, President of the Chamber, D. Šváby (Rapporteur), S. Rodin, K. Jürimäe and P.G. Xuereb, Judges,

Advocate General: J. Kokott,

Registrar: A. Calot Escobar,

after hearing the Advocate General,

makes the following

Order

1

On 25 March 2021, the Court (Fourth Chamber) delivered the judgment in Xellia Pharmaceuticals and Alpharma v Commission (C‑611/16 P, EU:C:2021:245).

2

That judgment contains, in its introductory part, errors which it is appropriate to rectify at the request of the European Commission, pursuant to Article 154(1) of the Rules of Procedure of the Court of Justice, applicable to appeal proceedings in accordance with Article 190(1) of those rules.
 

On those grounds, the Court (Fourth Chamber) hereby orders:
 

1.

In the introductory part of the judgment of 25 March 2021, Xellia Pharmaceuticals and Alpharma v Commission (C‑611/16 P, EU:C:2021:245), the reference to the representatives of the European Commission shall be rectified as follows:

‘European Commission, represented by F. Castilla Contreras, T. Vecchi, B. Mongin and C. Vollrath, acting as Agents, and B. Rayment, Barrister,’

 

2.

The original of this order shall be annexed to the original of the rectified judgment. A note of this order shall be made in the margin of the original of the rectified judgment.

 

Luxembourg, 3 September 2021.

A. Calot Escobar

Registrar

M. Vilaras

President of the Fourth Chamber

( *1 ) Language of the case: English.

Top